ID   AROK_MYCTU              Reviewed;         176 AA.
AC   P9WPY3; L0TBI1; P0A4Z2; P95014;
DT   16-APR-2014, integrated into UniProtKB/Swiss-Prot.
DT   16-APR-2014, sequence version 1.
DT   07-APR-2021, entry version 40.
DE   RecName: Full=Shikimate kinase;
DE            Short=SK;
DE            EC=2.7.1.71;
GN   Name=aroK; OrderedLocusNames=Rv2539c; ORFNames=MTCY159.17;
OS   Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv).
OC   Bacteria; Actinobacteria; Corynebacteriales; Mycobacteriaceae;
OC   Mycobacterium; Mycobacterium tuberculosis complex.
OX   NCBI_TaxID=83332;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND SUBUNIT.
RX   PubMed=11483005; DOI=10.1006/prep.2001.1457;
RA   Oliveira J.S., Pinto C.A., Basso L.A., Santos D.S.;
RT   "Cloning and overexpression in soluble form of functional shikimate kinase
RT   and 5-enolpyruvylshikimate 3-phosphate synthase enzymes from Mycobacterium
RT   tuberculosis.";
RL   Protein Expr. Purif. 22:430-435(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=9634230; DOI=10.1038/31159;
RA   Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C.M., Harris D.E.,
RA   Gordon S.V., Eiglmeier K., Gas S., Barry C.E. III, Tekaia F., Badcock K.,
RA   Basham D., Brown D., Chillingworth T., Connor R., Davies R.M., Devlin K.,
RA   Feltwell T., Gentles S., Hamlin N., Holroyd S., Hornsby T., Jagels K.,
RA   Krogh A., McLean J., Moule S., Murphy L.D., Oliver S., Osborne J.,
RA   Quail M.A., Rajandream M.A., Rogers J., Rutter S., Seeger K., Skelton S.,
RA   Squares S., Squares R., Sulston J.E., Taylor K., Whitehead S.,
RA   Barrell B.G.;
RT   "Deciphering the biology of Mycobacterium tuberculosis from the complete
RT   genome sequence.";
RL   Nature 393:537-544(1998).
RN   [3]
RP   CRYSTALLIZATION.
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=11717501; DOI=10.1107/s0907444901014032;
RA   Gu Y., Reshetnikova L., Li Y., Yan H., Singh S.V., Ji X.;
RT   "Crystallization and preliminary X-ray diffraction analysis of shikimate
RT   kinase from Mycobacterium tuberculosis in complex with MgADP.";
RL   Acta Crystallogr. D 57:1870-1871(2001).
RN   [4]
RP   IDENTIFICATION AS A DRUG TARGET [LARGE SCALE ANALYSIS].
RX   PubMed=19099550; DOI=10.1186/1752-0509-2-109;
RA   Raman K., Yeturu K., Chandra N.;
RT   "targetTB: a target identification pipeline for Mycobacterium tuberculosis
RT   through an interactome, reactome and genome-scale structural analysis.";
RL   BMC Syst. Biol. 2:109-109(2008).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=21969609; DOI=10.1074/mcp.m111.011627;
RA   Kelkar D.S., Kumar D., Kumar P., Balakrishnan L., Muthusamy B., Yadav A.K.,
RA   Shrivastava P., Marimuthu A., Anand S., Sundaram H., Kingsbury R.,
RA   Harsha H.C., Nair B., Prasad T.S., Chauhan D.S., Katoch K., Katoch V.M.,
RA   Kumar P., Chaerkady R., Ramachandran S., Dash D., Pandey A.;
RT   "Proteogenomic analysis of Mycobacterium tuberculosis by high resolution
RT   mass spectrometry.";
RL   Mol. Cell. Proteomics 10:M111.011627-M111.011627(2011).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) IN COMPLEX WITH MG-ADP, COFACTOR, AND
RP   KINETIC PARAMETERS.
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=12054870; DOI=10.1016/s0022-2836(02)00339-x;
RA   Gu Y., Reshetnikova L., Li Y., Wu Y., Yan H., Singh S.V., Ji X.;
RT   "Crystal structure of shikimate kinase from Mycobacterium tuberculosis
RT   reveals the dynamic role of the LID domain in catalysis.";
RL   J. Mol. Biol. 319:779-789(2002).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) IN COMPLEX WITH SHIKIMATE AND MG-ADP,
RP   AND COFACTOR.
RX   PubMed=15583379; DOI=10.1107/s090744490402517x;
RA   Pereira J.H., de Oliveira J.S., Canduri F., Dias M.V.B., Palma M.S.,
RA   Basso L.A., Santos D.S., de Azevedo W.F. Jr.;
RT   "Structure of shikimate kinase from Mycobacterium tuberculosis reveals the
RT   binding of shikimic acid.";
RL   Acta Crystallogr. D 60:2310-2319(2004).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) IN COMPLEX WITH SHIKIMATE AND ADP.
RX   PubMed=15358538; DOI=10.1016/j.febslet.2004.08.005;
RA   Dhaliwal B., Nichols C.E., Ren J., Lockyer M., Charles I.G., Hawkins A.R.,
RA   Stammers D.K.;
RT   "Crystallographic studies of shikimate binding and induced conformational
RT   changes in Mycobacterium tuberculosis shikimate kinase.";
RL   FEBS Lett. 574:49-54(2004).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) IN COMPLEX WITH SUBSTRATES.
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=16834327; DOI=10.1021/bi0606290;
RA   Gan J., Gu Y., Li Y., Yan H., Ji X.;
RT   "Crystal structure of Mycobacterium tuberculosis shikimate kinase in
RT   complex with shikimic acid and an ATP analogue.";
RL   Biochemistry 45:8539-8545(2006).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.35 ANGSTROMS) OF APOENZYME AND IN COMPLEX WITH
RP   SUBSTRATES AND PRODUCTS, FUNCTION, AND REACTION MECHANISM.
RC   STRAIN=ATCC 25618 / H37Rv;
RX   PubMed=17020768; DOI=10.1016/j.jmb.2006.09.001;
RA   Hartmann M.D., Bourenkov G.P., Oberschall A., Strizhov N., Bartunik H.D.;
RT   "Mechanism of phosphoryl transfer catalyzed by shikimate kinase from
RT   Mycobacterium tuberculosis.";
RL   J. Mol. Biol. 364:411-423(2006).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.93 ANGSTROMS) IN COMPLEX WITH SHIKIMATE AND
RP   MG-ADP.
RX   PubMed=17183161; DOI=10.1107/s1744309106046823;
RA   Dias M.V.B., Faim L.M., Vasconcelos I.B., de Oliveira J.S., Basso L.A.,
RA   Santos D.S., de Azevedo W.F. Jr.;
RT   "Effects of the magnesium and chloride ions and shikimate on the structure
RT   of shikimate kinase from Mycobacterium tuberculosis.";
RL   Acta Crystallogr. F 63:1-6(2007).
CC   -!- FUNCTION: Catalyzes the specific phosphorylation of the 3-hydroxyl
CC       group of shikimic acid using ATP as a cosubstrate.
CC       {ECO:0000269|PubMed:11483005, ECO:0000269|PubMed:17020768}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + shikimate = 3-phosphoshikimate + ADP + H(+);
CC         Xref=Rhea:RHEA:13121, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:36208, ChEBI:CHEBI:145989, ChEBI:CHEBI:456216;
CC         EC=2.7.1.71;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:12054870, ECO:0000269|PubMed:15583379};
CC       Note=Binds 1 Mg(2+) ion per subunit. {ECO:0000269|PubMed:12054870,
CC       ECO:0000269|PubMed:15583379};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=410 uM for shikimate {ECO:0000269|PubMed:12054870};
CC         KM=83 uM for ATP {ECO:0000269|PubMed:12054870};
CC   -!- PATHWAY: Metabolic intermediate biosynthesis; chorismate biosynthesis;
CC       chorismate from D-erythrose 4-phosphate and phosphoenolpyruvate: step
CC       5/7.
CC   -!- SUBUNIT: Monomer. {ECO:0000269|PubMed:11483005,
CC       ECO:0000269|PubMed:12054870, ECO:0000269|PubMed:15358538,
CC       ECO:0000269|PubMed:15583379, ECO:0000269|PubMed:16834327,
CC       ECO:0000269|PubMed:17020768, ECO:0000269|PubMed:17183161}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.
CC   -!- DOMAIN: Consists of three domains: the CORE domain which forms the
CC       binding site for nucleotides, the LID domain which closes over the
CC       active site upon ATP or shikimate binding, and the substrate-binding
CC       domain which functions to recognize and bind shikimate.
CC   -!- MISCELLANEOUS: The phosphoryl transfer proceeds by an in-line
CC       associative mechanism. The random sequential binding of shikimate and
CC       nucleotide is associated with domain movements that suggest a synergic
CC       mechanism by which binding of the first substrate may enhance the
CC       affinity for the second substrate.
CC   -!- MISCELLANEOUS: Was identified as a high-confidence drug target.
CC   -!- SIMILARITY: Belongs to the shikimate kinase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL123456; CCP45334.1; -; Genomic_DNA.
DR   PIR; G70658; G70658.
DR   RefSeq; NP_217055.1; NC_000962.3.
DR   RefSeq; WP_003413021.1; NZ_NVQJ01000032.1.
DR   PDB; 1L4U; X-ray; 1.80 A; A=1-176.
DR   PDB; 1L4Y; X-ray; 2.00 A; A=1-176.
DR   PDB; 1U8A; X-ray; 2.15 A; A=1-176.
DR   PDB; 1WE2; X-ray; 2.30 A; A=1-176.
DR   PDB; 1ZYU; X-ray; 2.90 A; A=1-176.
DR   PDB; 2DFN; X-ray; 1.93 A; A=1-176.
DR   PDB; 2DFT; X-ray; 2.80 A; A/B/C/D=1-176.
DR   PDB; 2G1J; X-ray; 2.00 A; A/B=1-176.
DR   PDB; 2G1K; X-ray; 1.75 A; A=1-176.
DR   PDB; 2IYQ; X-ray; 1.80 A; A=1-176.
DR   PDB; 2IYR; X-ray; 1.98 A; A/B=1-176.
DR   PDB; 2IYS; X-ray; 1.40 A; A=1-176.
DR   PDB; 2IYT; X-ray; 1.47 A; A=1-176.
DR   PDB; 2IYU; X-ray; 1.85 A; A=1-176.
DR   PDB; 2IYV; X-ray; 1.35 A; A=1-176.
DR   PDB; 2IYW; X-ray; 1.85 A; A=1-176.
DR   PDB; 2IYX; X-ray; 1.49 A; A=1-176.
DR   PDB; 2IYY; X-ray; 1.62 A; A=1-176.
DR   PDB; 2IYZ; X-ray; 2.30 A; A=1-176.
DR   PDB; 3BAF; X-ray; 2.25 A; A=1-176.
DR   PDB; 4BQS; X-ray; 2.15 A; A/B/C=1-176.
DR   PDBsum; 1L4U; -.
DR   PDBsum; 1L4Y; -.
DR   PDBsum; 1U8A; -.
DR   PDBsum; 1WE2; -.
DR   PDBsum; 1ZYU; -.
DR   PDBsum; 2DFN; -.
DR   PDBsum; 2DFT; -.
DR   PDBsum; 2G1J; -.
DR   PDBsum; 2G1K; -.
DR   PDBsum; 2IYQ; -.
DR   PDBsum; 2IYR; -.
DR   PDBsum; 2IYS; -.
DR   PDBsum; 2IYT; -.
DR   PDBsum; 2IYU; -.
DR   PDBsum; 2IYV; -.
DR   PDBsum; 2IYW; -.
DR   PDBsum; 2IYX; -.
DR   PDBsum; 2IYY; -.
DR   PDBsum; 2IYZ; -.
DR   PDBsum; 3BAF; -.
DR   PDBsum; 4BQS; -.
DR   SMR; P9WPY3; -.
DR   STRING; 83332.Rv2539c; -.
DR   PaxDb; P9WPY3; -.
DR   GeneID; 887434; -.
DR   KEGG; mtu:Rv2539c; -.
DR   TubercuList; Rv2539c; -.
DR   eggNOG; COG0703; Bacteria.
DR   OMA; EVRDPLY; -.
DR   PhylomeDB; P9WPY3; -.
DR   Reactome; R-MTU-964903; Chorismate via Shikimate Pathway.
DR   UniPathway; UPA00053; UER00088.
DR   Proteomes; UP000001584; Chromosome.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IDA:MTBBASE.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:MTBBASE.
DR   GO; GO:0004765; F:shikimate kinase activity; IDA:MTBBASE.
DR   GO; GO:0009073; P:aromatic amino acid family biosynthetic process; IEA:UniProtKB-UniRule.
DR   GO; GO:0008652; P:cellular amino acid biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0009423; P:chorismate biosynthetic process; IBA:GO_Central.
DR   GO; GO:0019632; P:shikimate metabolic process; IDA:MTBBASE.
DR   CDD; cd00464; SK; 1.
DR   HAMAP; MF_00109; Shikimate_kinase; 1.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR031322; Shikimate/glucono_kinase.
DR   InterPro; IPR000623; Shikimate_kinase/TSH1.
DR   InterPro; IPR023000; Shikimate_kinase_CS.
DR   Pfam; PF01202; SKI; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS01128; SHIKIMATE_KINASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Amino-acid biosynthesis; Aromatic amino acid biosynthesis;
KW   ATP-binding; Cytoplasm; Kinase; Magnesium; Metal-binding;
KW   Nucleotide-binding; Reference proteome; Transferase.
FT   CHAIN           1..176
FT                   /note="Shikimate kinase"
FT                   /id="PRO_0000192393"
FT   NP_BIND         12..17
FT                   /note="ATP"
FT   REGION          112..124
FT                   /note="LID domain"
FT   METAL           16
FT                   /note="Magnesium"
FT   BINDING         34
FT                   /note="Substrate"
FT   BINDING         58
FT                   /note="Substrate"
FT   BINDING         80
FT                   /note="Substrate; via amide nitrogen"
FT   BINDING         117
FT                   /note="ATP"
FT   BINDING         136
FT                   /note="Substrate"
FT   BINDING         153
FT                   /note="ATP"
FT   STRAND          4..8
FT                   /evidence="ECO:0007744|PDB:2IYV"
FT   HELIX           15..26
FT                   /evidence="ECO:0007744|PDB:2IYV"
FT   STRAND          30..32
FT                   /evidence="ECO:0007744|PDB:2IYV"
FT   HELIX           33..41
FT                   /evidence="ECO:0007744|PDB:2IYV"
FT   HELIX           45..52
FT                   /evidence="ECO:0007744|PDB:2IYV"
FT   HELIX           54..71
FT                   /evidence="ECO:0007744|PDB:2IYV"
FT   STRAND          74..77
FT                   /evidence="ECO:0007744|PDB:2IYV"
FT   HELIX           82..84
FT                   /evidence="ECO:0007744|PDB:2IYV"
FT   HELIX           86..92
FT                   /evidence="ECO:0007744|PDB:2IYV"
FT   STRAND          97..101
FT                   /evidence="ECO:0007744|PDB:2IYV"
FT   HELIX           104..110
FT                   /evidence="ECO:0007744|PDB:2IYV"
FT   TURN            111..113
FT                   /evidence="ECO:0007744|PDB:1L4U"
FT   HELIX           118..121
FT                   /evidence="ECO:0007744|PDB:2IYS"
FT   STRAND          122..124
FT                   /evidence="ECO:0007744|PDB:2IYX"
FT   HELIX           125..143
FT                   /evidence="ECO:0007744|PDB:2IYV"
FT   STRAND          145..149
FT                   /evidence="ECO:0007744|PDB:2IYV"
FT   STRAND          151..153
FT                   /evidence="ECO:0007744|PDB:2IYV"
FT   HELIX           155..163
FT                   /evidence="ECO:0007744|PDB:2IYV"
FT   HELIX           173..176
FT                   /evidence="ECO:0007744|PDB:2IYV"
SQ   SEQUENCE   176 AA;  18583 MW;  208EE0C38F5186A1 CRC64;
     MAPKAVLVGL PGSGKSTIGR RLAKALGVGL LDTDVAIEQR TGRSIADIFA TDGEQEFRRI
     EEDVVRAALA DHDGVLSLGG GAVTSPGVRA ALAGHTVVYL EISAAEGVRR TGGNTVRPLL
     AGPDRAEKYR ALMAKRAPLY RRVATMRVDT NRRNPGAVVR HILSRLQVPS PSEAAT
//
